LH

#521
Labcorp Holdings Inc. Common Stock
260.3 0 USD
-0.93%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
259.90
262.60
Jahresspanne
2.53
291.64
Tagesänderung
-0.93%
Monatliche Änderung
-2.05%
6 month change
-3.05%
Jahresänderung
-6.74%
Vorheriger Schlusskurs
262.7 5
Open
262.5 1
Tief
259.9 0
High
262.6 0
Volumen
826
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 21.34 B
  • Employee 71 K
  • Founded 1978
  • CEO Adam H. Schechter
  • Website www.labcorp.com
  • Headquarter North Carolina, United States
  • FIGI BBG01MMT6PL7
  • Industry Diagnostik und Untersuchungen
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
23.63
Preis-Umsatz-Verhältnis
1.58
Dividende je Aktie
0.72
Dividendenrendite in %
1.89

Labcorp Holdings Inc. Common Stock

Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.

Nachrichten